SM Gold will hold a meeting of the Board of Directors of the Company on 9 April 2022
Darshan Orna will hold a meeting of the Board of Directors of the Company on 9 April 2022
TVS Motor Company announced that its wholly owned subsidiary TVS Motor Singapore has acquired a majority stake 70Percentage in EBCO a British company providing smart connected solutions based in United Kingdom and thereby it has become a subsidiary of TVS Motor Singapore as well as the company EBCO is a British company providing smart connected mobility solutions through a pipeline of e-bikes across the city […]
Srestha Finvest will hold a meeting of the Board of Directors of the Company on 5 April 2022
Maharashtra Scooters will hold a meeting of the Board of Directors of the Company on 25 April 2022
Hero MotoCrop sold 450154 units in March 2022 This is a sequential growth over the volume sales in the month of February when Hero MotoCorp dispatched 358254 units of motorcycles and scooters indicating a gradual recovery in the economy In FY22 the auto industry witnessed significant disruptions triggered by the second and third wave of Coronavirus pandemic restricting customer movement Hero MotoCorp sold 4944150 units […]
Veer Global Infraconstruction will hold a meeting of the Board of Directors of the Company on 6 April 2022
Colinz Laboratories will hold a meeting of the Board of Directors of the Company on 15 April 2022
Power Grid Corporation of India POWERGRID has transferred balance 26Percentage equity shareholding of POWERGRID Vizag Transmission PVTL to PGlnvlT on 31 March 2022 at a consideration of Rs 33078 crore after adjustments of dividend received by POWERGRID from PVTL With this POWERGRID has Nil shareholding in PVTL; and POWERGRID has relinquished its right on additional revenue accruing to POWERGRID Parli Transmission POWERGRID Warora Transmission and […]
Dr Reddys Laboratories has entered into an agreement with Novartis AG to acquire the cardiovascular brand Cidmus in India Under the agreement Dr Reddys will be assigned and transferred the Cidmus trademark in India from Novartis AG for a consideration of USD 61 million The Cidmus brand shall be affixed on the pharmaceutical composition comprising a combination of Valsartan and Sacubitril currently under Novartis patent […]
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
